Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw
Completed · Phase 1
Conditions studied: Blood Loss, Healthy
In brief
Zynex's blood volume monitor (BVM) is a non-invasive monitoring device to monitor blood volume and blood loss of a patient during surgery, post operatively and/or in recovery. This monitoring device will identify baseline blood volume and relative changes in blood volume using a specific algorithm to compare and review data already monitored during surgery, displaying blood volume and blood loss in real-time.
Key facts
- Study ID
- NCT01646060
- Run by
- Zynex Monitoring Solutions
- People needed
- 10
- Starts
- 2011-11-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2012-07-20
Who can join
Age: 18 and older, up to 65. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Written informed consent
- Male, 18-65 years of age
- Subject is suitable for a blood draw of a pint of blood
- Weighs at least 110 pounds
You may not qualify if…
- Subject has a heart condition that may interfere with the Zynex CM-1500
- Subject has unstable or untreated heart disease
- Subject has been diagnosed with chronic fatigue syndrome
- Subject is taking coumadin (warfarin), heparin, or other prescription blood thinners for at least 7 days prior to blood draw
- Subject donated blood within 8 weeks prior to blood draw
- Subject has high or low blood pressure on the day of blood draw
- Subject hemoglobin < 12.5 g/dL
Where it is running
- Rocky Mountain Urgent Care — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.